Correlation of Levels of Platinum and Selenium in Rats Treated with Cisplatin and Sodium Selenite
The ability of selenium compounds to reduce the toxicity of mercury compounds has been demonstrated in animals (Parizek and Ostadalove 1967; Hill 1974) and humans (Kosta et al. 1975), the molar ratio of mercury to selenium being approx-imately 1 : 1 in certain organs after this combination therapy. Among selenium compounds, sodium selenite was found by us (Komiya et al. 1977) to have the most powerful protective effect against toxicity of mercuric chloride.
KeywordsNeutron Activation Analysis Testicular Cancer Subcellular Fraction Sodium Selenite Mercuric Chloride
Unable to display preview. Download preview PDF.
- Einhorn LH, Donohue JP (1977) Cis-Daminedichloroplatinum, vinblastine and bleomycin combination chemotherapy in disseminated testicular cancer. Ann Int Med 87: 293–298Google Scholar
- Heydorn K (1983) Trace elements in clinical chemistry determined by neutron activation analysis. In: Sigel H (ed) Metal ions in biological systems vol 16. Dekker, New York, Basel, p 123Google Scholar
- Hill CH (1974) Reversal of selenium toxicity in chicks by mercury, copper and cadmium. J Nutr 104:593–598Google Scholar
- Komiya K, Koike I, Kawauchi S, Sakurai H (1977) Studies on protective effect of mercurial toxicity by selenium I: relationship between protective effects of various selenium compounds on the toxicity of mercuric chloride and distributions of mercury and selenium in rat tissues. Eisei Kagaku 23: 235–243CrossRefGoogle Scholar
- Lowry OH, Rosenbrough NJ, Farr AL, Randell RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 93: 265–275Google Scholar